NCT02610933View on ClinicalTrials.gov

Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 23, 2019

Study Completion Date

January 23, 2019

Conditions

Vascular Calcification

Interventions

DRUG

rivaroxaban

replacement of vitamin K antagonist by rivaroxaban

DIETARY_SUPPLEMENT

Vitamin K2

Vitamin K2 supplementation

Trial Locations (1)

9300

OLV Hospital, Aalst

All Listed Sponsors

lead

Onze Lieve Vrouw Hospital

OTHER

NCT02610933 - Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients | Biotech Hunter | Biotech Hunter